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Transcriptional regulation in eukaryotes occurs at
promoter-proximal regions wherein transcription-
ally engaged RNA polymerase II (Pol II) pauses
before proceeding toward productive elongation.
The role of chromatin in pausing remains poorly
understood. Here, we demonstrate that the histone
deacetylase SIRT6 binds to Pol II and prevents the
release of the negative elongation factor (NELF),
thus stabilizing Pol II promoter-proximal pausing.
Genetic depletion of SIRT6 or its chromatin defi-
ciency upon glucose deprivation causes intragenic
enrichment of acetylated histone H3 at lysines 9
(H3K9ac) and 56 (H3K56ac), activation of cyclin-
dependent kinase 9 (CDK9)—that phosphorylates
NELF and the carboxyl terminal domain of Pol II—
and enrichment of the positive transcription elon-
gation factors MYC, BRD4, PAF1, and the super
elongation factors AFF4 and ELL2. These events
lead to increased expression of genes involved
in metabolism, protein synthesis, and embryonic
development. Our results identified SIRT6 as a
Pol II promoter-proximal pausing-dedicated his-
tone deacetylase.INTRODUCTION
Environmental adaptation is a fundamental trait of all living organ-
isms. Individual cells rely on molecular sensors altering their ac-
tivities in response to environmental dynamics, such as nutrient
availability. The mammalian sirtuin family of proteins (SIRT1-7)
are NAD+-dependent deacetylases capable of sensing changes
in nutrient conditions to remodel cellular metabolism (Sebastia´n
et al., 2012a; Choi andMostoslavsky, 2014; Etchegaray andMos-
toslavsky, 2016). SIRT6 is an histone H3K9ac and H3K56 deace-
tylase, affecting multiple gene networks involved in glucose
metabolism, DNA repair, nuclear factor kB (NF-kB) signaling,
tumorigenesis, early development, and aging (Kawahara et al.,
2009; Michishita et al., 2008, 2009; Yang et al., 2009; Zhong
et al., 2010; Sebastia´n et al., 2012b; Kanfi et al., 2012; Toiber
et al., 2013; Kugel and Mostoslavsky, 2014; Silberman et al.,
2014; Etchegaray et al., 2015; Kugel et al., 2015, 2016). The de-
acetylation activity of SIRT6 was also shown to protect telomeric
regions from genomic instability (Michishita et al., 2008, 2009)
and to promote efficient repair of DNA double-strand breaks
(Mao et al., 2011; Toiber et al., 2013). Additionally, SIRT6 can
also deacetylate H3K18ac on pericentric chromatin as a potential
mechanism to prevent DNA erosion upon cell division during
cellular senescence (Tasselli et al., 2016). Our earlier work pro-
vided strong evidence for SIRT6 roles in repressing expression
of glycolytic, ribosomal, and developmental genes (Sebastia´n
et al., 2012b; Zhong et al., 2010; Etchegaray et al., 2015; FerrerMolecular Cell 75, 1–17, August 22, 2019 ª 2019 Elsevier Inc. 1
Figure 1. SIRT6 Regulates Transcriptional Pausing via Deacetylation of H3K9ac and H3K56ac
(A) Integrative genomics viewer (IGV) browser (Robinson et al., 2011; Thorvaldsdo´ttir et al., 2013) images of read coverage across the genome. Images of tiled
data files (TDFs) generated by the displaying the density tracks of reads aligned across the genome. The tracks show ChIP-seq maps of Pol II on SIRT6 target
genes Pdk4, Dgat2, Ltv1, and Fads2 in WT (black) and SIRT6 KO (red) ESCs.
(B) Western blots showing levels of Pol II and Pol II Ser2P in the chromatin fraction isolated from WT and SIRT6 KO ESCs.
(legend continued on next page)
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A key regulatory step during transcription occurs during
promoter-proximal pausing of RNA polymerase II (Pol II), at
30–60 nt downstream of the transcription start site (TSS)
(Rahl et al., 2010; Bartkowiak et al., 2010; Adelman and Lis,
2012). Pol II pausing is mainly regulated by two pausing-promot-
ing factors, DSIF (DRB-sensitive inducing factor) and NELF
(negative elongation factor), which is composed of four subunits
(NELF-A, NELF-B, NELF-C/-D, and NELF-E) (Wada et al., 1998;
Yamaguchi et al., 1999; Narita et al., 2003; Adelman and Lis,
2012). The release of paused Pol II into productive transcription
elongation is facilitated by the recruitment of CDK9-containing
P-TEFb (positive transcription elongation factor b), which phos-
phorylates the C-terminal domain (CTD) of Pol II at serine 2
(Ser2P) aswell as the pausing factors resulting in the dissociation
of NELF from chromatin and the conversion of DSIF into an elon-
gation-stimulating factor (Marshall et al., 1996; Marshall and
Price, 1995; Wei et al., 1998; Fujinaga et al., 2004; Adelman
and Lis, 2012; Yamada et al., 2006).
Depending on genetic and cellular contexts, the recruitment of
P-TEFb was proposed to be facilitated by c-MYC (MYC), BRD4,
aswell as different subunits from theMediator complex including
MED23, via interaction withMYC,MED26, and the super elonga-
tion complex (SEC) (Rahl and Young, 2014; Liu et al., 2015; Li
et al., 2018). BRD4 is a member of the bromodomain and ex-
tra-terminal domain (BET) family of transcription factors, which
are recruited to acetylated chromatin to promote transcription
elongation (Winter et al., 2017). However, the mechanisms
downstream of BRD4 that govern release of Pol II pausing into
productive elongation remain unclear. Notably, in vitro systems
using reconstituted chromatinized templates demonstrated
that the histone acetyltransferase p300 activity is required for
efficient transcription and served to elucidate the role of tran-
scription factors involved in Pol II pausing and elongation (Kim
et al., 2010; Pavri et al., 2006).
Acetylation of histones was also shown to stimulate produc-
tive transcriptional elongation in live cells (Stasevich et al.,
2014). More recently, H3K9ac was shown to release Pol II
pausing into transcription elongation by recruiting the SEC com-
plex and thereby loss of H3K9ac caused an increase in Pol II
pausing at specific genes in HeLa cells (Gates et al., 2017).
These studies indicate that transcriptional pausing could be
regulated at the level of chromatin deacetylation. However,
the histone deacetylase(s) modulating the transition between
transcriptional pausing and productive elongation remained
unknown. Here, we show that the histone deacetylase SIRT6
interacts with Pol II and inhibits transcription elongation by(C and D) Permanganate footprinting (C) and real-time qPCR (D) showing levels of
(gray), and SIRT6 KO ESCs (red). Samples were normalized to actin and shown as
(E) Western blots showing levels of SIRT6 and H3 in chromatin fraction from WT
chromatin from SIRT6 KO ESCs grown in normal glucose conditions.
(F) IGV browser images from SIRT6 ChIP-seq showing SIRT6 target genes Pdk1
(G) Scatter plot analysis showing H3K9ac or H3K56ac on upregulated (green) an
upregulated genes exhibit increased signal in the KO cells.
(H) Graphical quantification of the data on (G).
(I) Metagene analysis showing enrichment of H3K9ac or H3K56ac at intragenic r
(J) IGV browser images from H3K9ac and H3K56ac ChIP-seq in SIRT6 KO (red)decreasing intragenic levels of acetylated H3K9 and H3K56
to modulate recruitment of specific transcription factors. Our re-
sults identify SIRT6 as a dedicated chromatin deacetylase for
modulating transcriptional pausing and elongation.
RESULTS
SIRT6-Dependent Histone Deacetylation of H3K9ac and
H3K56ac Regulate Transcriptional Elongation
To investigate the role of SIRT6 in transcriptional regulation,
we performed chromatin immunoprecipitation sequencing
(ChIP-seq) analysis in wild type (WT) and SIRT6 knockout
(KO) embryonic stem cells (ESCs), using antibodies targeting
RNA Pol II (Figure 1A). Notably, we found decreasing levels
of Pol II at proximal-promoter sites (dotted blue line square)
while increasing amounts within intragenic regions (dotted
green line square) on multiple SIRT6 target genes, including
Pdk4, Dgat2, Ltv1, and Fads2 in SIRT6 KO compared to
WT ESCs. This differential pattern of gene-loaded Pol II be-
tween WT and SIRT6 KO suggested that SIRT6 could influence
a transition from a promoter-proximal paused Pol II to an
elongating state. The phosphorylation of Pol II within its
carboxyl terminal domain at serine 2 (Pol II S2P) is a hallmark
for productive transcription elongation (for review, see Jonkers
and Lis, 2015). In this context, we found a global increase in the
levels of Pol II S2P on chromatin from SIRT6 KO ESCs
(Figure 1B).
To further assess roles for SIRT6 in transcriptional regulation,
we performed permanganate DNA footprinting, one of the
most authoritative means to detect paused polymerase in vivo
(Nechaev et al., 2010). We analyzed two representative SIRT6
target genes, lactose dehydrogenase b (Ldhb) and glucose
transporter 1 (Glut1) (Figure 1C) (Zhong et al., 2010). We found
Pol II pausing on both genes at promoter-proximal regions
(between +48 and +59 on Ldhb and +31 on Glut1) in WT cells.
Notably, SIRT6 KO ESCs exhibited a stronger signal within the
same regions, showing increased trafficking of Pol II at pro-
moter-proximal sites, indicative of increased transcriptional
elongation (Samarakkody et al., 2015). Importantly, increased
Pol II trafficking was also observed in WT ESCs grown under
glucose deprivation (Figure 1C), demonstrating that SIRT6 defi-
ciency mimics conditions of nutrient stress (Etchegaray and
Mostoslavsky, 2016; Zhong et al., 2010). Accordingly, increased
mRNA levels for Ldhb and Glut1 were similar both in WT ESCs
following glucose deprivation and SIRT6 KO ESCs (Figure 1D),
in parallel to the global dissociation of SIRT6 from chromatin
following glucose removal from the culturing media (Figure 1E).
Using ChIP-seq analysis, we determined that SIRT6 localizesLdhb andGlut1 genes in WT ESCs grown in high glucose (black) or no glucose
ratios over WT samples (*p < 0.05, **p < 0.01, n > 3; error bar represents SEM).
ESCs grown in normal glucose (0 h) or under no glucose for 24 h or 48 h and
, Ldha, and Glut1 and Ltv1 in WT (black) and in SIRT6 KO ESCs (red).
d downregulated (red) genes in SIRT6 KO versus WT ESCs. Note that only the
egions in SIRT6 KO (red) compared to WT (black) ESCs.
versus WT ESCs (black) on Ldhb and Pdk1 genes.
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Figure 2. Global Decrease of Pol II Pausing in ESCs Lacking SIRT6
(A) Co-localization of SIRT6 and Pol II. Heatmaps showing Pol II and SIRT6 ChIP-seq signal within 3 kb genomic windows flanking the TSS (the TSS is denoted as
an arrow) in WT and SIRT6 KO ESCs. The SIRT6 heatmap on SIRT6 KO ESCs was included as a control.
(B) IGV browser images for of Pol II and SIRT6 ChIP-seq on the SIRT6 target genes Ldha and Ak4.
(C) IGV browser images fromPol II ChIP-seq showing increased levels on Pol II at intragenic regions (gene bodies) in SIRT6 KO (red) compared toWTESCs (black)
on SIRT6 target genes (Ldhb and Ak4).
(D) IGV browser images from PRO-seq analysis showing increase levels on Pol II at gene bodies in SIRT6 KO (red) compared to WT ESCs (black) on SIRT6 target
genes (Ldhb and Ak4).
(legend continued on next page)
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including Pdk1, Ldha, Glut1, and Ltv1 (Figure 1F). Furthermore,
by using ChIP-qPCR we also found that SIRT6 binding is lost
in WT ESCs cultured under conditions of glucose starvation (Fig-
ure S1A). These results support a role for SIRT6 in regulating
transcription elongation via Pol II promoter-proximal pausing.
As mentioned above, SIRT6 represses transcription by acting
as a specific deacetylase for H3K9ac and H3K56ac (Zhong et al.,
2010; Sebastia´n et al., 2012b; Etchegaray et al., 2015; Kugel
et al., 2016). Thus, we performed ChIP-seq experiments in WT
and SIRT6 KO ESCs to identify the genomic regions targeted
by SIRT6-dependent histone deacetylation impacting gene
expression, as determined by RNA sequencing (RNA-seq) anal-
ysis (Table S1). RNA- seq identified 4,938 genes upregulated and
4,534 genes downregulated in SIRT6 KO cells. We focused on
the upregulated genes, given the likelihood that downregulated
genes cannot be explained as direct targets of a deleted histone
deacetylase. From the nearly 5,000 genes upregulated in SIRT6
KO ESCs, 1,200 genes have enriched levels of both H3K9ac
and H3K56ac, and 1,800 genes are enriched for either
H3K9ac or H3K56ac (Figure S1B), indicating thatmost genes up-
regulated in the SIRT6 KO cells are direct targets of SIRT6.
Furthermore, we observed a specific enrichment of these his-
tone marks only on genes that are upregulated in SIRT6 KO
ESCs, not the downregulated ones (Figures 1G and 1H; green
dots compared to red dots, respectively).
Next, using metagene analysis, we found that the increase in
H3K9ac and H3K56ac occurs mainly at promoter-proximal re-
gions and gene bodies (Figures 1I, 1J, and S1C). In addition to
metabolism and pluripotency, the genes impacted by SIRT6
removal were also enriched for neural development ontologies
(Table S2), which is consistent with the neural-skewed pheno-
type we observed upon differentiation of SIRT6 KO ESCs (Etch-
egaray et al., 2015). These results indicate that SIRT6 has a
prominent role in modulating histone acetylation within intra-
genic regions encompassing promoter-proximal pausing and
gene bodies. This ability of SIRT6 to regulate intragenic histone
acetylation as a potential mean to modulate Pol II pausing and
elongation is different from the known roles of class I and class
II histone deacetylases (HDACs) that work predominantly at
TSS regions, affecting Pol II recruitment at promoter sites (Jones
et al., 1998; Nan et al., 1998).
SIRT6 Supports Transcriptional Promoter-Proximal
Pausing
To identify the genes mostly affected by SIRT6-dependent Pol II
pausing, we first mapped the binding of SIRT6 and Pol II in
mouse ESCs in a genome-wide manner. Consistent with the dis-(E) Metagene profile, from Pol II ChIP-seq analysis, showing a decrease in Pol II
overall increased intragenic Pol II levels in SIRT6 KO ESCs. Inset: zoom-in of intra
(F) Pausing index, calculated from Pol II ChIP-seq analysis, is decreased in SIRT
(G) Metagene profile, from PRO-seq analysis, showing an overall increased intrage
of intragenic regions highlighting the higher levels of Pol II in SIRT6 KO cells (p <
(H) Pausing index, calculated from PRO-seq analysis, is decreased in SIRT6 KO
(I) Metagene profile, from PRO-seq analysis, showing an overall increased intrag
(black) grown under normal conditions. Inset: zoom-in of intragenic regions high
(J) Decreased pausing index, calculated from PRO-seq analysis, in glucose deptribution of histone marks, and in contrast to other HDACs (Ram
et al., 2011), SIRT6 localized at promoter-proximal pausing sites
downstream of the TSS and closely following the positional
pattern of Pol II throughout the genome (Figure 2A). Furthermore,
when compared to WT, Pol II binding on SIRT6 KO cells exhibits
a more diffuse pattern, suggesting increased intragenic binding
(Figure 2A). When zoomed in at known SIRT6-targeted genes
(Figure 2B-D), a prominent co-localization between Pol II and
SIRT6 is observed near promoter-proximal sites. These results
indicate that SIRT6 and Pol II are positioned together at the
pausing site of these genes.
We next determined whether SIRT6 directly interact with Pol II.
Indeed, endogenous SIRT6 co-immunoprecipitated (coIP) with
Pol II in WT ESCs, even in the presence of ethidium bromide,
indicating that these proteins interact in a direct fashion (Figures
S2C–S2E). We further validated this result bymass spectrometry
analysis and confirmed interaction of SIRT6 with one of the large
subunits of Pol II, RPB2 (Figure S2F), as previously demon-
strated by proteomic analysis (Miteva and Cristea, 2014). We
next performed metagene analysis of Pol II ChIP-seq data from
WT and SIRT6 KO ESCs and identified a significant increase
in intragenic signal and a concomitant decrease of promoter-
proximal signal for Pol II in SIRT6 KO cells (Figure 2E). Alto-
gether, these results indicate a global role for SIRT6 in inhibiting
Pol II transition from promoter-proximal regions to intragenic
sites, a transition that is accompanied by active transcriptional
elongation.
We next used the Pol II ChIP-seq analysis to calculate pausing
index (PI) (Rahl et al., 2010) in WT and SIRT6 KO ESCs cells.
Notably, SIRT6 KO cells exhibited a global decrease in PI (Fig-
ures 2F and S2G), with over two thousand genes shifted toward
an increased productive elongation state. To establish whether
these Pol II pausing dynamics correspond to transcriptional
changes, we performed a comparative analysis between Pol II
ChIP-seq and RNA-seq from WT and SIRT6 KO ESCs (Table
S3). Nearly half of the upregulated genes (2,459 out of the
4,938 genes upregulated in SIRT6 KO ESCs, 49.7%) show >2-
fold decrease in PI compared to WT ESCs, providing evidence
for their regulation by pausing and elongation (Figure S2G).
Furthermore, these gene sets showing decreased PI include
genes involved in metabolic processes and neural development,
consistent with the role of SIRT6 as a key regulator of both meta-
bolism (Kugel and Mostoslavsky, 2014) and early embryonic
development (Etchegaray et al., 2015; Ferrer et al., 2018) (Fig-
ures S2A and S2B; Table S3).
To confirm these results using an orthogonal approach, we
performed precision nuclear run-on sequencing (PRO-seq) anal-
ysis (Mahat et al., 2016). PRO-seq identifies nascent RNA in alevels near TSS in SIRT6 KO ESCs (red) compared to WT cells (black) and an
genic regions highlighting the higher levels of Pol II in SIRT6 KO cells (p < 0.04).
6 KO compared to WT (gray) ESCs.
nic Pol II levels in SIRT6 KO (red) compared toWT (black) ESCs. Inset: zoom-in
0.0001).
(red) compared to WT (black) ESCs (p < 0.0001).
enic Pol II levels in glucose deprived WT ESCs (green) versus WT control cells
lighting the higher levels of Pol II in glucose deprived WT cells (p < 0.0001).
rived WT ESCs (green) compared to WT control cells (black) (p < 0.0001).
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Figure 3. SIRT6 Is an Integral Component of the Pol II Transcription Pausing Machinery
(A) Western blot showing decreased levels of chromatin-bound NELF-E in SIRT6 KO compared to WT ESCs.
(B) IGV browser images fromCUT&RUN assays for NELF-E and H3K9ac inWT (black) and SIRT6 KOESCs (red). TSS regions are denoted as +1 and directionality
of transcription by the arrow. Levels of NELF-E and H3K9ac near TSS are highlighted inside the blue dotted line square.
(C) Metagene profile for NELF-E coverage in SIRT6 KO (red) versus WT ESCs shows a drastic decrease of NELF-E at promoter-proximal regions.
(D) Phosphorylated NELF-E (P-NELF-E) levels increased in SIRT6 KO and glucose starved WT ESCs compared to WT controls. Western blots showing
immunoprecipitation of NELF-E blotted with anti-Phospho-CDK9 substrate and anti-NELF-E antibodies in WT, WT no glucose and SIRT6 KO ESCs.
(legend continued on next page)
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olution, allowing us to evaluate Pol II pausing and elongation in
WT versus SIRT6 KO ESCs using an independent approach.
Metagene analysis confirmed the decrease Pol II binding at
TSS and concomitant increased in signal at gene bodies (Figures
2G and S2I; Table S4). Furthermore, from a total of 3,659 upregu-
lated genes (based on a minimum of 16 reads of Pol II binding;
see STAR Methods), and consistent with the Pol II ChIP-seq
data analysis described above, we found 2,746 genes (75%)
with significantly decreased PI (Figures 2H and S2H). Moreover,
thismolecular phenotype of decreased PI in SIRT6KOESCswas
recapitulated in WT ESCs cultured under glucose deprivation
(Figures 2I, 2J, and S2I; Table S4). As control for this approach,
we found no significant differences in the levels of intragenic Pol
II on genes whose expression is unchanged between WT and
SIRT6 KO (Figures S2J and S2K). Importantly, between the
two methodologies we used to determine PI (Pol II ChIP-seq
and PRO-seq), we found an overlapping of 2,022 genes
(80%) that exhibit lower PI in both assays (Table S5). Collec-
tively, using two distinct approaches, we determined that a sig-
nificant fraction of genes de-repressed in the absence of SIRT6
exhibit decreased transcriptional promoter-proximal pausing,
resulting in more Pol II engaged in productive elongation.
SIRT6 Supports Pol II Pausing by Preventing Eviction of
NELF-E from Chromatin
Promoter-proximal pausing requires the association of Pol II with
the negative transcription elongation factors NELF and DSIF
(Kwak and Lis, 2013). Subunits of these negative elongation fac-
tors, including NELF-E and SPT5, are phosphorylated by CDK9
(Fujinaga et al., 2004; Jonkers and Lis, 2015; Ping and Rana,
2001). Phosphorylated NELF-E dissociates from chromatin,
while SPT5 phosphorylation converts DSIF into a positive
elongation factor, leading to productive transcription elongation
(Yamada et al., 2006; Gaertner and Zeitlinger, 2014). Given
the above results, we next examined whether NELF was altered
in SIRT6 KO cells. Strikingly, chromatin levels of NELF-E
decreased in SIRT6 KO ESCs (Figure 3A). Similar results were
also observed in mouse embryonic fibroblasts (MEFs) derived
from SIRT6 KO mice (Figure S3A). Notably, this phenotype can
be rescued by expressing a copy of WT SIRT6 (Figure S3A), indi-
cating that the reduction in chromatin-bound NELF-E is depen-
dent on SIRT6. Additionally, binding of NELF-E to chromatin
was also gradually diminished upon glucose withdrawal in WT
ESCs (Figure S3B).
To specifically investigate NELF binding on SIRT6 target
genes, we next performed both CUT&RUN (Skene et al., 2018)
and ChIP-qPCR experiments. Indeed, we saw loss of NELF-E(E) CDK9-dependent in vitro kinase assay. CDK9 was immunoprecipitated from e
conjugated with a synthetic GST-tagged carboxyl terminal domain of Pol II pepti
CDK9 inhibitor DRB. A representative experiment is shown.
(F) Western blot analysis showing decreasing chromatin levels of Pol II S2P by a
KO ESCs.
(G) Real-time PCR showing levels of Ldhb and Glut1 genes with or without DRB
(H) Western blots showing chromatin levels for Pol II, Pol II Ser2P, CDK9, BRD4, M
histone H3 in WT and SIRT6 KO ESCs.
(I) Western blots showing increased coIP of CDK9 with Pol II Ser2P, BRD4, MYCat the promoter-proximal regions of SIRT6 target genes in
SIRT6 KO ESCs (Figure 3B; note the increased H3K9Ac in the
same regions). From 9,000 genes with lower levels of NELF-E
in SIRT6 KO compared to WT ESCs, 1,040 genes have low PI
(Figure S3C). Consistently, metagene analysis shows decrease
levels of NELF-E in SIRT6 KO ESCs at promoter-proximal re-
gions (Figure 3C; Table S6). We also observed a tight correlation
between CUT&RUN and ChIP-seq for H3K9ac, thereby support-
ing the validity of the CUT&RUN approach (Figure S3D). Addi-
tionally, by ChIP-qPCR, we observed decreased levels of
NELF-E near promoter-proximal regions, on Ldhb and Glut1
genes in SIRT6 KO ESCs as well as WT cells cultured under
glucose deprivation (Figure S3E). These results indicate that
chromatin-bound NELF depends on SIRT6 tomaintain Pol II pro-
moter-proximal pausing in ESCs.
Because CDK9-dependent phosphorylation is a pre-requisite
for the release of NELF-E from chromatin (Fujinaga et al., 2004),
we next examined the phosphorylation status of NELF-E in
SIRT6 KO versus WT ESCs grown under normal or glucose-
deprived conditions. Indeed, phosphorylation of NELF-E was
increased in both SIRT6 KO ESCs and glucose-depleted WT
ESCs, compared to WT ESCs grown under normal nutrient con-
ditions (Figure 3D). These results, together with the increased Pol
II phosphorylation we observe in the SIRT6 KO cells (Figure 1B),
suggested that eviction or depletion of SIRT6 from its target
genes triggers the activation and/or increase recruitment of
CDK9. To evaluate this hypothesis, we used an in vitro kinase
assay and found that CDK9 purified from SIRT6 KO ESCs ex-
hibits increased kinase activity in comparison to CDK9 purified
from WT ESCs (Figure 3E). This increased kinase activity is sen-
sitive to the CDK9 inhibitor DRB (5,6-dichloro-1-b-D-ribofurano-
syl-1H-benzimidazole). Accordingly, coIP with CDK9 shows
increased Pol II Ser2P levels in SIRT6 KO compared to WT
ESCs (Figure S3F).
To further confirm that upregulation of SIRT6-targeted genes
is CDK9-dependent, we treated ESCs with the CDK9 inhibitor
DRB. Efficient inhibition of CDK9 was confirmed by measuring
phosphorylation of Pol II (Ser2P) in a dose-dependent manner
(Figure 3F). TreatmentwithDRB rescued theupregulated expres-
sion of Ldhb and Glut1 in SIRT6 KO cells (Figure 3G). These
experiments indicate that SIRT6 sustains Pol II promoter-prox-
imal pausing by preventing CDK9-dependent phosphorylation
of NELF-E and Pol II (Ser2P). Importantly, in addition to the
increased activity of CDK9, we observed higher levels of this
kinase in the chromatin fraction of SIRT6 KO ESCs (Figure 3H).
Multiple transcription factors were shown to be involved in
Pol II pausing release, including MYC (reviewed in Rahl and
Young, 2014), the bromodomain protein BRD4 (Yang et al.,ither WT or SIRT6 KO ESCs and in vitro kinase assay was performed on beads
de (GST-CTD) in the presence of 32p-gATP, in the presence or absence of the
dding the CDK9 inhibitor DRB in a dose-dependent manner to WT and SIRT6
treatment in WT and SIRT6 KO ESCs.
YC, PAF1, AFF4, ELL2, MED23, NELF-E, SIRT6, H3K56ac, H3K9ac, and total
, and MED23 in SIRT6 KO ESCs.
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Figure 4. SIRT6 Regulates Transcription by
Modulating the Levels of Chromatin-Bound
MYC
(A) Western blots showing chromatin bound MYC
and levels H3K9ac and H3K56ac in WT, glucose-
deprived WT, and SIRT6 KO ESCs.
(B) MYC ChIP-qPCR experiments in Ldhb and
Glut1 genes. Schematic representation for these
genes are shown below. Samples were normalized
to input and further normalized to IgG ChIP con-
trols (*p < 0.05, **p < 0.005, ***p < 0.0005, n = 3;
error bar represents SEM).
(C) Real-time qPCR analysis showing RNA levels
for the metabolic genes Ldha, Ldhb, Glut1, Pdk1,
and the ribosomal genes Rpl3, Rpl5, Rpl6 upon
MYC knockdown (shMyc) or a control short hairpin
RNA (shRNA) (shCtrl) in WT, glucose-deprivedWT,
and SIRT6 KO ESCs (*p < 0.05, n = 3; error bar
represents SEM).
(D) Western blot analysis showing decreased Pol II
S2P, BRD4, and CDK9 on chromatin of SIRT6 KO
ESCs upon acute MYC knockdown using two
distinct siRNA oligos. H3 is shown as loading
control for chromatin fractions. Cytosolic fractions
show the rescue of PDK1 and LDH levels upon
acute MYC knockdown in SIRT6 KO ESCs. Actin is
included as a loading control.
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subunit of the mediator complex, MED23, which has been asso-
ciated with Pol II transcriptional pause release depending on
BRD4 (Wang et al., 2005; Lu et al., 2016), AFF4 and ELL2, which
are component of the multi-subunit SEC (Lin et al., 2010; He
et al., 2010; Lu et al., 2016), and the Pol II associated factor 1
(PAF1), which is a component of the PAF1multi-subunit complex
(PAF1C) (Van Oss et al., 2017). Strikingly, all of these factors
exhibit increased chromatin levels in SIRT6 KO compared to
WT ESCs (Figure 3H). Because P-TEFb, which contains CDK9,
is recruited to promoter-proximal pausing sites by some of these
transcription factors, such as MYC, BRD4, and MED23 (re-
viewed in Rahl and Young, 2014; Jonkers and Lis, 2015; Lu
et al., 2016), we next assessed levels of these factors by coIP
with CDK9. Consistently, we find higher levels of BRD4, MYC
and MED23 to coIP with CDK9 in SIRT6 KO compared to WT
ESCs (Figure 3I), further indicating that SIRT6 inhibits the forma-
tion of this multi-protein complex on chromatin.8 Molecular Cell 75, 1–17, August 22, 2019Increased Transcription Elongation
in SIRT6 KO ESCs Is Dependent on
MYC, BRD4, and PAF1
MYC has been proposed as a key modu-
lator of transcriptional elongation (Rahl
et al., 2010). Following our observation
of increased levels of MYC in the chro-
matin fraction of SIRT6 KO ESCs (Fig-
ure 3H), we investigated the role of MYC
in the assembly of elongation factors
and its effect on gene expression in
SIRT6 KO ESCs. We first demonstrate
that binding of MYC to chromatin is signif-icantly increased in SIRT6 KO ESCs and in glucose-deprivedWT
ESCs paralleling the increase in H3K9ac and H3K56ac levels
(Figure 4A). Furthermore, ChIP-qPCR experiments demon-
strated increased binding of MYC to Ldhb and Glut1 genes in
SIRT6 KO ESCs, particularly near promoter-proximal pausing
sites (Figure 4B), supporting the known role of MYC as a tran-
scription elongation promoting factor (Rahl et al., 2010). Consis-
tently, MYC knockdown inhibited the expression of various
SIRT6-targeted genes, including metabolic and ribosomal pro-
tein genes (Figure 4C). MYC deficiency also caused a reduction
in CDK9 recruitment and the levels of Pol II (Ser2P), while total
Pol II amounts remain unchanged in chromatin from WT and
SIRT6 KO ESCs (Figures 4D and S4A). Consistent with the
real-time qPCR results, the increase in protein levels of the
SIRT6 targets LDHA and PDK1 was fully rescued upon MYC
knockdown (Figure 4D, lower panel). Importantly, H3K9 acetyla-
tion was not affected by knocking downMYC in SIRT6 KOESCs,
confirming that recruitment of MYC occurs downstream of
A B
DC
Figure 5. SIRT6 Controls the Assembly of
Transcription Elongation and Super Elonga-
tion Factors
(A) Western blots from whole cell extracts show
levels of PDK1 and LDHA rescued upon acute
siRNA-mediated knockdown of BRD4 and/or
PAF1 in SIRT6 KO ESCs.
(B) Real-time qPCR analysis showing cDNA
levels for Pdk1, Ldha, and Ldhb in WT and SIRT6
KO ESCs following siRNA-mediated knockdown
of BRD4 (siBrd4) and/or PAF1 (siPAF1). Samples
were normalized to Actin levels (*p < 0.05, **p <
0.01, ***p < 0.001, n = 3; error bar represents
SEM).
(C) Western blots showing decreased levels of Pol
II Ser2P, in SIRT6 KOESCs following acute siRNA-
dependent BRD4 knockdown (siBRD4).
(D) Western blots showing chromatin levels of
BRD4, PAF1, MYC, AFF4, ELL2, SIRT6, and
histone H3 in WT and SIRT6 KO ESCs upon
acute siRNA-mediated knockdown of BRD4 and/
or PAF1.
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in histone acetylation (Figure 4D). Together, these results
suggest a positive feedback loop between CDK9 and MYC dur-
ing transcriptional elongation, as previously proposed (Huang
et al., 2014).
Given the enrichment of H3K9ac and H3K56ac intragenically
(compare SIRT6 KO versusWT ESCs) (Figures 1G–1J and S1C),
we asked whether readers of these marks may be important in
this phenotype. The bromodomain-containing factor BRD4
directly binds acetylated histones and can potentially influence
the recruitment of MYC and the activation of CDK9, in turn facil-
itating transcriptional elongation (Kanno et al., 2014; Yang et al.,
2005; Lu et al., 2015; Cheung et al., 2017). Additionally, inhibition
of BRD4, using BET inhibitors such as JQ1, was shown to impair
ESC self-renewal/pluripotency and to promote cell fate commit-Mment to the neuroectodermal lineage (Di
Micco et al., 2014), both phenotypes
regulated by SIRT6 (Etchegaray et al.,
2015; Ferrer et al., 2018).
We observed an increased recruit-
ment of BRD4 in chromatin from SIRT6-
depleted cells (ESCs and MEFs) (Figures
3H and S4B, respectively). Thus, we
reasoned that BRD4 may play a role in
the release of paused Pol II and tested
whether deficiency of BRD4 could rescue
gene expression and transcription elon-
gation phenotypes in SIRT6 KO ESCs.
While levels of Pol II remain unchanged,
small interfering RNA (siRNA)-mediated
knockdown of BRD4 reduced Pol II
(Ser2P) levels and decreased the expres-
sion of SIRT6 targets (Pdk1, Ldha, and
Ldhb) (Figures 5A–5D and S4C), indi-
cating a relevant role for BRD4 in SIRT6-
dependent regulation of transcriptionelongation. Moreover, BRD4 knockdown lead to a decrease in
chromatin MYC in the absence of SIRT6 (Figure 5D), thus sup-
porting a model for BRD4-dependent recruitment of MYC that
triggers the release of paused Pol II into transcription elongation.
Notably, WT ESCs appear more resistant to BRD4 knockdown
compared to SIRT6 KO ESCs, suggesting that highly acetylated
chromatin, due to the absence of SIRT6, is more permissive of
BRD4-mediated transcription (Figure 5D).
The PAF1 complex (PAF1C) has been implicated both as a
positive (Yu et al., 2015) and negative regulator (Chen et al.,
2015) of Pol II pausing release into productive transcription elon-
gation. More recently, comparative three-dimensional studies of
paused Pol II and elongating Pol II complexes clearly demon-
strated a positive role for PAF1C in facilitating transcription elon-
gation (Vos et al., 2018a; Vos et al., 2018b). Consistent with theolecular Cell 75, 1–17, August 22, 2019 9
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upregulation of SIRT6-targets can be rescued by knocking down
one of its subunits, PAF1 (Figures 5A and 5B). Furthermore, the
recruitment of BRD4 and MYC along with the SEC components
AFF4 and ELL2 was severely decreased on chromatin from
SIRT6 KO cells upon PAF1 knockdown (Figure 5D). Importantly,
knockdown of BRD4 also decreased binding of PAF1, MYC, and
the SEC factors (Figure 5D), indicating that both BRD4 and PAF1
may be reinforcing a positive feedback to sustain high levels of
these factors on chromatin.
Next, to fully demonstrate a role for PAF1C in the context of
SIRT6 regulation, we performed ChIP-seq analysis with an anti-
body targeting LEO1, a subunit of PAF1C (Van Oss et al., 2017).
Consistently, in cells lacking SIRT6, we observed increased
binding of LEO1 onmultiple SIRT6-target genes, includingmeta-
bolism, ribosomal biogenesis, neural development, and pluripo-
tency (Figures 6A and S4D; Table S7). The PAF1 complex has
also been implicated in facilitating the recruitment of P-TEFb to
facilitate phosphorylation of Pol II (Ser2P) (Lu et al., 2016).
Indeed, we found that in the absence of SIRT6, the Pol II fraction
interacting with different components of the PAF1 complex is
highly enriched for Pol II (Ser2P) (Figure 6B). Moreover, higher
levels of LEO1 coIP with CDK9 in SIRT6 KO compared to WT
ESCs (Figure S4E). Additionally, we found augmented levels of
the SEC component AFF4 to coIPwith LEO1 and another subunit
of the PAF1 complex, CDC73, in SIRT6 KO ESCs (Figure 6B).
These results are consistent with previous studies showing
that SEC factors can modulate P-TEFb recruitment via interac-
tion with PAF1C (Lu et al., 2016).
Last, by employing ChIP-qPCR, we found an enrichment of
the SEC factors ELL2 and AFF4 in SIRT6 KO ESCs specifically
at intragenic regions within the SIRT6-target genes Ldhb and
Glut1 (Figure 6C). All together, these results indicate that in the
absence of SIRT6, both PAF1C and SEC complexes are re-
cruited to chromatin in a coordinated fashion to facilitate tran-
scription elongation of SIRT6-target genes.
SIRT6-Dependent Histone Deacetylation Aligns with
H3K36me3 and H3K79me2 Patterns on Genes Involved
in Metabolism and Development
Methylation of H3 at lysine 36 (H3K36me3) and 79 (H3K79me2)
has been previously associated with active transcriptional elon-
gation (Guenther et al., 2007; Pokholok et al., 2005).We analyzed
the genomic levels of these histone modifications in WT versus
SIRT6 KO ESCs and found that many of the genes whose
expression is upregulated in the absence of SIRT6 are enriched
for H3K36me3 and/or H3K79me2 (Figure 7A; Table S2). Consis-
tent with our previous studies (Sebastia´n et al., 2012b; Etche-
garay et al., 2015), H3K36me3 and H3K79me2 are enriched at
genes involved in metabolic pathways and neural development
(Table S2). Although a modest number of genes are enriched
for all these epigenetic marks (H3K9ac, H3K56ac, H3K36me3,
and H3K79me2) (Figure S5A), a larger number of genes (300
genes), whose expression is upregulated in SIRT6 KO ESCs,
exhibit at least two of these epigenetic marks (Table S2). Plau-
sibly, diverse combinations for these histone marks may be suf-
ficient to trigger transcription elongation in the absence of SIRT6
(see Discussion below).10 Molecular Cell 75, 1–17, August 22, 2019SIRT6 Depletion Triggers Increased Transcriptional
Elongation in an In Vitro Assay
To further demonstrate that SIRT6 function as a regulator of Pol II
pausing release, we used an in vitro transcription elongation
assay containing a pre-assembled chromatinized DNA template
reconstituted with purified transcription factors from HeLa cells,
in the presence of p300/acetyl-CoA, as previously described
(Kim et al., 2010). This in vitro elongation reaction was supple-
mented with nuclear extracts from SIRT6 knockdown versus
control HeLa cells (Figure 7B). Strikingly, we observed a time-
dependent increase of the fully elongated transcript (390 nt) in
the presence of the SIRT6-depleted nuclear extract, compared
to control (Figures 7C and 7D). Comparable levels of the pre-
initiated transcript (17 nt) can be observed with a shorter expo-
sure time (Figure S5B). This in vitro transcription elongation
approach provides additional evidence that SIRT6 regulates
transcription during the transition between pausing and produc-
tive elongation.
DISCUSSION
In this study, we demonstrate that SIRT6 is a key regulator of Pol
II promoter-proximal pausing. Under normal nutrient conditions,
SIRT6 forms a complex with Pol II and maintains histone H3 in a
deacetylated state to stabilize Pol II promoter-proximal pausing.
Release of SIRT6 from chromatin results in augmented intra-
genic histone acetylation, thereby facilitating the recruitment of
BRD4 and P-TEFb. Beyond increased recruitment of P-TEBb,
we observed increased activity of the CDK9 kinase. Notably,
the inactive form of CDK9 within the P-TEFb complex, is
maintained by its binding to HEXIM1 and the 7SK small nuclear
ribonucleoprotein particle (snRNP) RNA (Guo and Price, 2013).
However, coIP experiments with CDK9 shows no difference in
the levels of HEXIM1 interacting with CDK9 in WT and SIRT6
KO ESCs (Figure S3G), suggesting that the increased activity
of CDK9 observed in the KO cells is not dependent on HEXIM1
regulation, but rather may depend on the increased interaction
with Pol II and the elongation promoting factors MYC, BRD4,
and MED23 (Figure 3I).
This, in turn, causes the phosphorylation and chromatin evic-
tion of NELF-E and the accumulation of Pol II (Ser2P), which
facilitates the recruitment of elongation promoting factors
including MYC, PAF1, MED23, and the SEC factors AFF4
and ELL2, together leading to the release of Pol II promoter-
proximal pausing into productive transcription elongation (Fig-
ure 7E). Mechanistically, our results demonstrate that SIRT6-
dependent histone deacetylation is critical for maintaining the
chromatin landscape in a state that supports Pol II pausing at
promoter-proximal regions and prevent productive elongation
of target genes. A trigger to inactivate SIRT6 and promote elon-
gation of specific gene sets may depend on cues originated
from nutritional changes, developmental stages or proliferation
signals.
Although years of research have demonstrated the require-
ment for histone acetylation in promoting transcription elonga-
tion in vivo and in vitro (Guermah et al., 2006; Kim et al., 2010;
Pavri et al., 2006), the specific deacetylase(s) inhibiting tran-
scription elongation at Pol II promoter-proximal pausing sites
A B
C
Figure 6. The PAF1 Complex Is a Positive Regulator of Transcription Elongation in ESCs Lacking SIRT6
(A) Increased recruitment of the PAF1C subunit LEO1 in SIRT6 KO ESCs at specific genes. IGV browser images of LEO1 ChIP-seq in SIRT6 KO (red) versusWT
ESCs (black) on genes implicated in metabolism (Ldhb, Ak4, Car2) and neural development (Igfbp2, Crmp1, Zic5).
(B)Western blot analysis showing increased coIP of PAF1C components PAF1, LEO1, and CDC73with Pol II, Pol II Ser2P, and the super elongation factor AFF4 in
chromatin fractions from SIRT6 KO compared to WT ESCs.
(C) Enrichment of SEC complex at intragenic regions of SIRT6 target genes. ChIP-qPCR analysis of super elongation factors ELL2 and AFF4 at various genomic
regions of Ldhb andGlut1 genes, inWT (black) versus SIRT6 KO (red) ESCs. Schematic representation of the Ldhb andGlut1 genes and the location of the regions
targeted for qPCR is shown below.
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Figure 7. SIRT6-Dependent Chromatin Dynamics Regulates Pol II Elongation
(A) IGV browser images showing the enrichment of H3K36me3 and H3K79me2 on metabolic (Ldhb, Ak4, Car2) and neural developmental (Igfbp2, Crmp1, Zic5)
genes in WT (black) and SIRT6 KO (red) ESCs.
(B) Scheme of the in vitro transcription elongation protocol using a chromatinized DNA template.
(C) In vitro transcription elongation assay showing and augmentation of full elongation capacity in the absence of SIRT6.
(D) Quantification of full elongation products from (C).
(E) Model of SIRT6-dependent regulation of transcription elongation. Under normal nutrient conditions, SIRT6 forms a complex with Pol II at promoter-proximal
regions where NELF is retained during transcriptional pausing. In this complex, SIRT6 maintains histone H3 in a deacetylated state on its targeted genes, thereby
(legend continued on next page)
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nistic analysis of a histone deacetylase dedicated to controlling
the release of paused Pol II into productive transcription elonga-
tion, a function that could confer cells with unique capabilities to
fine-tune transcription in response to environmental cues. For
instance, dynamic chromatin regulation of Pol II pausing can
mediate faster and/or more synchronous modulation of gene
expression in response to developmental and nutrient signals.
Indeed, transcriptional synchronicity could ensure the orches-
tration of complex gene regulatory networks controlling
mammalian embryogenesis, in accordance to earlier findings
demonstrating fine-tuned orderly gene activation patterns in
Drosophila embryos (Lagha et al., 2013; Boettiger and Levine,
2009). Overall, in the context of ESCs, we propose that this
SIRT6-dependent chromatin structure/transcriptional mode
may be context-specific. We consider this mechanism to have
evolved in order to respond to cellular states and/or environ-
mental cues, via the control of specific gene sets in a robust
and synchronous manner. However, our data do not rule out
the possibility that SIRT6 might also influence transcription initi-
ation (we sawmodest but consistent differences in histone acet-
ylation and Pol II levels at TSS as well), a relevant question that
will be addressed in future work. The involvement of other HDAC
family members (class I and II) in transcriptional regulation has
been shown to be predominantly at the level of gene promoters.
For instance, the HDAC1-containing co-repressor complexes
N-CoR and Sin3A limit the accessibility of transcription initiation
factors to gene promoters (Nagy et al., 1997; Alland et al., 1997;
Heinzel et al., 1997). The human NuRD co-repressor complex,
containing both HDAC1 and HDAC2, represses transcription
by limiting the chromatin access of basal transcription factors
to promoter regions (Zhang et al., 1997; Tong et al., 1998; Xue
et al., 1998).
The PAF1 complex has been proposed to function as an acti-
vator or repressor of transcription elongation depending on ge-
netic/cellular contexts (Van Oss et al., 2017). PAF1 was also
found at enhancer regions to restrain transcription on specific
gene subsets (Chen et al., 2017). More recently, 3D studies
demonstrated that PAF1C functions as a positive transcription
elongation factor by displacing NELF from paused Pol II (Vos
et al., 2018a, 2018b). Our findings support a role for PAF1C as
an activator of transcription elongation, as originally determined
in both mouse (Strikoudis et al., 2016) and human ESCs (Yu
et al., 2015). Additionally, PAF1C is required for themaintenance
of pluripotency in both mouse and human ESCs (Ding et al.,
2009; Rigbolt et al., 2011; Ponnusamy et al., 2009). Finally, we
demonstrated that levels of PAF1 in chromatin are increased
in SIRT6 KO ESCs (Figure 5C), which we have previously
showed to have an increased capacity to maintain expression
of pluripotency genes (Etchegaray et al., 2015; Ferrer et al.,
2018). Thereby, PAF1C might serve as part of a gatekeeper
mechanism to uphold the pluripotency state in ESCs by promot-facilitating Pol II pausing. However, under poor nutrient conditions such as gluc
histone H3, which triggers the recruitment of BRD4 and MYC. This facilitate th
phosphorylation and chromatin eviction of NELF. Activated P-TEFb also phospho
the release of transcriptional pausing. Subsequent recruitment of additional factor
impel transcription into productive elongation mode.ing transcription elongation of pluripotency-related genes. In
this context, we observed increased interaction of the PAF com-
plex with members of the SEC (Figure 6B) on chromatin, likely
due to increase levels of these factors in the absence of
SIRT6, further indicating enhanced elongation when SIRT6 is
removed from chromatin. Of note, this function of PAF1C might
differ upon differentiation, in other cell types or under conditions
of disease.
The levels of H3K56ac were shown to correlate with transcrip-
tion elongation in both yeast and Drosophila (Schneider et al.,
2006). Thus, the role of H3K56ac as a positive modulator of tran-
scriptional elongation seems to be evolutionary conserved. In
addition, it was recently shown that H3K9ac is necessary for
the release of paused Pol II by directly recruiting the SEC in
HeLa cells (Gates et al., 2017). Removal of SIRT6 from chromatin
increases acetylated levels of both H3K9 and H3K56, thereby
explaining the enhanced recruitment of SEC components in
SIRT6 KO ESCs. In addition, acetylation of histones serves as
docking sites for the recruitment of BET bromodomain proteins,
such as BRD4, which function asmaster transcription elongation
factors (Winter et al., 2017). Importantly, we found that recruit-
ment of MYC on chromatin is severely impaired upon BRD4
knockdown in the context of SIRT6 depletion, in line with a
decreased expression of SIRT6 target genes (Figures 5A, 5B,
and 5D). This supports a model where BRD4 is responsible for
recruiting MYC onto SIRT6-depleted chromatin to release Pol
II pausing. BRD4 was shown to recruit the H3K36 methyltrans-
ferase NSD3 to increase gene expression (Rahman et al.,
2011; Shen et al., 2015), while MYC interacts with DOT1L, the
only known histone methyltransferase to catalyze methylation
of H3K79, to induce transcription activation (Cho et al., 2015;
Wong et al., 2017). Thus, the enhanced recruitment of BRD4
and MYC to the chromatin fraction that follows the increased
levels of H3K9ac and/or H3K56ac upon SIRT6 depletion, may
account for the enrichment of H3K36me3 and/or H3K79me2,
thereby contributing to the upregulated transcriptional elonga-
tion phenotype in SIRT6 KO ESCs. Given our previous studies
defining SIRT6 as a co-repressor of MYC in development and
cancer (Etchegaray et al., 2015; Kugel et al., 2015, 2016; Sebas-
tia´n et al., 2012b), our new results indicate that such modulation
may depend on the ability of SIRT6 to fine-tune gene expression
via transcriptional pausing and elongation to ensure proper
cellular differentiation during embryonic development and to
protect against malignant transformation.STAR+METHODS
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Rabbit anti-SIRT6 Cell Signaling Tech Cat#12486S; RRID: AB_2636969
Rabbit anti-H3K56ac Abcam Cat#ab76307; RRID: AB_1523762
Rabbit anti-H3K9ac Abcam Cat#ab1791; RRID: AB_302613
Mouse anti-Pol II (Rpb1) Cell Signaling Tech Cat#2629; RRID: AB_2167468
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Rabbit anti-AFF4 Lin et al., 2010 N/A
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Chemicals, Peptides, and Recombinant Proteins
5,5,6 5,6 Dichlorobenzimidazole 1-b-D-ribofuranoside Sigma-Aldrich D1916
GST-CTD Pol II Abcam ab81888
Protein A-MNase Skene et al., 2018 N/A
Biotin-11-CTP PerkinElmer NEL542001EA
Biotin-11-UTP PerkinElmer NEL543001EA
Biotin-11-ATP PerkinElmer NEL544001EA
Biotin-11-GTP PerkinElmer NEL545001EA
Critical Commercial Assays
RNA TriPure Isolation Reagent Roche Cat #11 667 157 001
QuantiTect Reverse Transcription Kit QIAGEN Cat #205310
SYBR green master Mix Roche Cat #04 707 516 001
Deposited Data
Raw and analyzed data This paper Database GEO: GSE130689
Database GEO: GSE130690
Database GEO: GSE130691
Database GEO: GSE130692
Experimental Models: Cell Lines
SIRT6 KO Embryonic Stem Cells (ES) cells Mostoslavsky et al., 2006 N/A
Oligonucleotides
Primers for Pro-seq, see STAR Methods This paper N/A
Primer: GFP/YFP/CFP Forward: GCACGACTTCTTCA
AGTCCGCCATGCC
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tophat2 version 2.0.10 Kim et al., 2013 http://ccb.jhu.edu/software/tophat
HTseq version 0.6.1 Anders et al., 2015 https://htseq.readthedocs.io/en/release_0.11.1/
DESeq2 Love et al., 2014 https://bioconductor.org/packages/release/bioc/
html/DESeq2.html
bwa version 0.7.13 Li and Durbin, 2010 http://bio-bwa.sourceforge.net
Diffbind Ross-Innes et al., 2012 https://bioconductor.org/packages/release/bioc/
html/DiffBind.html
MACS2 version 2.1 Zhang et al., 2008 https://github.com/taoliu/MACS
Picard tools N/A http://picard.sourceforge.net
Prism v8.1.2 N/A https://www.graphpad.com/scientific-software/prism/
bowtie v1.2.2 N/A http://bowtie-bio.sourceforge.net/index.shtml
cutadapt v1.14 N/A https://cutadapt.readthedocs.io/en/stable/
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
SIRT6 KO and WT ESCs in 129 strain genetic background (Mostoslavsky et al., 2006) were maintained on g-irradiated mouse
embryonic fibroblasts (MEFs) in knockout DMEMmedium (GIBCO) containing 15% ES-qualified FBS, 0.1 mM each of non-essential
amino acids, 2 mM L-glutamine, 0.1 mM b-mercaptoethanol, 50 units ml1 penicillin/streptomycin (Invitrogen) and supplemented
with leukemia inhibiting factor (LIF). For all experiments described, cells were trypsinized and plated for 30 min on standard tissue
culture dishes to remove feeder cells before floating ESCs were collected and re-plated on gelatin-coated dishes. For siRNA-
mediated knockdowns of BRD4, MYC and/or PAF1 we transfected synthetic siRNA oligos using Lipofectamine 2000, according
to the manufacturers protocol. The siRNA for BRD4 targets all mouse BRD4 isoforms (siGENOME SMARTpool from Dharmacon).
Hence, BRD4 protein levels were almost undetectable by western blot analysis. The expression of MYC and PAF1 was also knocked
down using siGENOME SMARTpool siRNA oligos from Dharmacon. For MYC knockdown we used two siRNA systems, the
oligo duplex (27-mers) from OriGene and siGENOME SMARTpool from Dharmacon. For glucose deprivation experiments,
ESCs were cultured with glucose-free DMEM with 15% FBS 0.1 mM each of non-essential amino acids, 2 mM L-glutamine,
0.1mM b-mercaptoethanol, 50 unitsml1 penicillin/streptomycin (Invitrogen) and supplemented with LIF for 2 days before harvesting
cells for biochemical assays.
METHOD DETAILS
Antibodies
The antibodies used for western blot analysis are: anti-SIRT6 (Abcam, ab62739), anti-NELF-E (Santa Cruz, sc32912), anti-Pol II (Cell
Signaling Tech., 2629), anti-Pol II S5P (Abcam, ab5131), anti-Pol II S2P (Millipore, 04-1571), anti-MYC (Abcam, ab32072), anti-BRD4
(Bethyl, 0301-985A50), anti-MED23 (BD PharMingen, 550429), anti-PAF1(D9G9X) (Cell Signaling Tech., 12883S), anti-LEO1 (Bethyl,
A300-175A), anti-CDK9 (Santa Cruz, sc-8338), anti-SPT5 (Bethyl., A300-868A), anti-PDK1 (Cell Signaling Tech., 3062S), anti-LDHA
(Cell Signaling Tech., 2012S), anti-phospho-pan antibody (Invitrogen, 61-8300), anti-Tubulin (Abcam, ab6160), Rabbit plyclonal
anti-AFF4 and anti-ELL2 antibodies (provided by Ali Shilatifard), anti-H3K9ac (Millipore, 07-352), anti-H3K56ac (Abcam, ab76307),
anti-H3 (Abcam, ab1791) and anti-actin (Sigma-Aldrich, A2066). Protein-protein immunoprecipitations were performed as previously
described (Lee et al., 2001). Antibodies targeting the super elongation factors AFF4 and ELL2 were provided by Ali Shilatifard.
The antibodies used for ChIP-RTqPCR, ChIP-seq and CUT&RUN analysis are: anti-MYC (Abcam, ab32072), anti-AFF4 and anti-
ELL2 antibodies (provided by Ali Shilatifard), anti-Pol II (Cell Signaling Tech., 2629), anti-SIRT6 (Cell Signaling Tech., 12486S), anti-
H3K9ac (Millipore 07-352), anti-H3K56ac (Abcam, ab76307), anti-H3K79me2 (Cell Signaling Tech., 5472), anti-H3K36me3 (Cell
Signaling Tech., 4909), anti-LEO1 (Bethyl, A300-175A) and anti-NELF-E (Abcam, ab170104).
Immunoblotting
Immunoblots were developed with HRP conjugated goat anti-rabbit (Sigma-Aldrich, AQ132P), goat anti-mouse (Sigma-Aldrich,
A3682) or goat anti-rat (Santa Cruz Biotech., sc-2006) secondary antibodies and ECL Plus (GE healthcare Lifescience, RPN2133).
Chromatin extraction and western blot analysis
For chromatin extractions, cell pellets were resuspended in lysis buffer (10mM HEPES pH 7.4, 10 mM KCl, 0.05% NP-40) supple-
mented with a protease inhibitor cocktail (Complete EDTA-free, Roche Applied Science), 5 mM TSA, 5mM sodium butyrate, 1mM
DTT, 1mM PMSF, 50mM NaF, 0.2mM sodium orthovanadate and phosphatase inhibitors (Phosphatase Inhibitor Cocktail Sets I
and II, Calbiochem) and incubated on ice for 20min. The lysate was then centrifuged at 14,000 rpm for 10min at 4C. The supernatant
was removed (cytosolic fraction) and the pellet (nuclei) was acid-extracted using 0.2NHCl and incubated on ice for 20min. The lysate
was then centrifuged at 14,000 rpm for 10 min at 4C. The supernatant (contains acid soluble proteins) was neutralized using 1M
Tris-HCl pH 8. Protein concentration was measured by Biorad Protein Assay. Western blot analyses were performed as previously
described (Zhong et al., 2010). Briefly, 10 ug of protein was loaded on a 10%–20%gradient polyacrylamide gel with SDS (Biorad) and
electroblotted onto polyvinylidene difluoride membranes (PVDF) (Millipore). Membranes were blocked in TBS with 5% non-fat milk
and 0.1% Tween and probed with antibodies. Bound proteins were detected with horseradish-peroxidase-conjugated secondary
antibodies (Vector Biolaboratories) and SuperSignal West Pico Luminol/Enhancer Solution (Thermo Scientific).
CDK9 Kinase Assay
Cells were collected in cold PBS and lysed in cold EBC buffer (50 mM Tris-HCl pH 8.0, NaCl 120 mM, 0.5% NP-40, 5 mMDTT). After
pre-clearing with protein-A beads for 2 hours at 4C, the lysates were incubated with either 3 ug CDK9 antibody (Santa CruzMolecular Cell 75, 1–17.e1–e7, August 22, 2019 e2
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were then washed 3 times with EBC + 0.05% SDS, then once with TKB/Mg buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 5 mM
DTT). The beads were resuspend in 25 ul of TKB/Mg buffer plus 2.5 mM MnCl2, 5 uM ATP, 200ng GST-CTD (Abcam ab81888),
and 5 uCi g-32P-ATP and incubated at room temperature for 40 minutes with or without 50 uM of the CDK9 inhibitor DRB (5,6-
Dichlorobenzimidazole 1-b-D-ribofuranoside) (Sigma-Aldrich, D1916). The reactions were stopped by adding 18 ul of 4x SDS loading
buffer and boil the sample 10 minutes at 95C. Samples were loaded in a polyacrylamide gel, which was then fixed with 40%
methanol + 10% acetic acid for 30min. Gels were washed three times for 5 min with Milli-Q H2O and stained with BioRad Coomassie
(161-0786) for 1 hour at room temperature. Additional washes with ddH2O were done to clear the background. Finally, the gel was
dried under a vacuum system, exposed and developed.
Protein-protein Immunoprecipitations
Protein-protein immunoprecipitations were performed as previously described (Lee et al., 2001). Briefly, whole cell lysates or
chromatin fractions were subjected to immunoprecipitation using magnetic Dynabeads Protein-A (Invitrogen, 10006D) or Protein-G
(Invitrogen, 10007D) immunoprecipitation kits. Prior immunoprecipitation, magnetic beads were conjugated with specific primary
antibodies (see list of antibodies above). Samples were incubated at 4Cwith constant rotation overnight in IP buffer (20 mMHEPES
pH 7.5, 1mMEDTA, 5mMNaF, 1mMDTT, 0.05%Triton X-100, 5%glycerol, 0.25mMPMSF plus protease inhibitors cocktail tablets
[Sigma-Aldrich, 4693116001]). Magnetic dynabeads containing immunoprecipitated samples were then washed twice with IP buffer
and 3 times with washing buffer supplied in the Dynabead kit.
RNA extraction and quantitative PCR with reverse transcription
Total RNA was extracted with the TriPure Isolation Reagent (Roche) as described by the manufacturer. For cDNA synthesis, 1 mg
of total RNA was retro-transcribed by using the QuantiTect Reverse Transcription Kit (QIAGEN). Real-time PCR was performed
using the SYBR green master mix (Roche), following the manufacturer’s instructions, with the exception that the final volume was
12.5 mL of SYBR green reaction mix. Real-time monitoring of PCR amplification was performed using the LightCycler 480 detection
system (Roche). Data were expressed as relative mRNA levels normalized to the b-actin expression level in each sample. The primer
sequences can be obtained on request. For RNA-Seq, total RNA purified with TriPure was cleaned up with RNeasy kits from
QIAGENe.
In vitro transcription elongation assay
The in vitro transcription elongation assaywas performed and analyzed as described earlier (Kim et al., 2010). Briefly, after the second
gel filtration, approximately 35 ng plasmid DNA-containing chromatin template was mixed with nuclear extract containing total 5 mg
protein which were prepared from control or SIRT6 knockdown HeLa cells. The extracts were adjusted to TX-buffer condition prior to
the addition. The reactions were 50ul in this step and incubated for 30 min at 30C. The reactions were then added with nucleotides
and RNasin in total 5 ul, and also adjusted to TX-buffer condition, which bring the final volume to 55ul, to allow the transcription
elongation. At the indicated time point, the reactions were stopped and transcription products were resolved by acrylamide gel
electrophoresis and visualized by X-ray film.
Permanganate footprinting
LigationMediated PCR (LM-PCR) based permanganate footprinting was done as described (Samarakkody et al., 2015). In brief, cells
were washed with 1xPBS and treated with 20mMKMn04 for 60 s on ice. Reactions were quenched with Stop buffer (1% SDS, 10mM
Tris HCl pH 8.0, 20mMEDTA, 0.5M 2-mercaptoethanol) and, after treatment with RNase cocktail (Ambion), Proteinase K and extrac-
tion with phenol-chloroform, DNA was ethanol-precipitated and resuspended in water at approximately 100 ng/ml. Up to 5 mg of DNA
was treated with 10% (v/v) piperidine in the final volume 100 ml, for 10 minutes at 90C, after which DNA was extracted with chloro-
form twice, ethanol precipitated in the presence of 10 mg GlycoBlue carrier, and resuspended in water at approximately 50 ng/ml.
Previously purified genomic DNA (naked DNA) was treated with permanganate and piperidine as above to establish background
DNA reactivity. Template for the A+G sequencing ladder was generated by treating purified DNA with formic acid (Maxam and
Gilbert, 1977) followed by piperidine treatment as above. Approximately 200 ng of piperidine-treated DNA was taken for each
Ligation-mediated (LM) PCR reaction. LM PCR began with primer extension with Primer A with Phusion DNA polymerase followed
by the addition of universal double-stranded linker (Samarakkody et al., 2015) and ligation with T4 DNA ligase. After ethanol precip-
itation, the ligated template was used for 22 cycles of PCR with gene-specific Primer B and Linker-specific primers, after which
50-32P-labeled primer was added and PCR continued for another 2 cycles. After phenol extraction and ethanol precipitation, DNA
was resuspended in 5 ml of 7M urea-1xTBE loading buffer and resolved on denaturing polyacrylamide sequencing gel followed by
radioautography. Footprints were quantified using ImageJ by subtracting the signal from naked DNA from reactivity of cells within
the pausing region. Primer sequences can be provided upon request.
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were performed as previously described (Gomes et al., 2006). Briefly, ESCs were
crosslinked with 1% formaldehyde/PBS for 15 min at room temperature. Crosslinking was quenched by addition of 0.125 M glycine.e3 Molecular Cell 75, 1–17.e1–e7, August 22, 2019
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to generate DNA fragments of approximately 0.5 kb. Approximately, 1 mg of pre-cleared protein extract was used for immunopre-
cipitation with the following specific antibodies: anti-Pol II (Cell Signaling Tech., 2629), anti-SIRT6 (Cell Signaling Tech., 12486S),
anti-NELF-E (Abcam), anti-MYC (Abcam, ab32072), anti- LEO1 (Bethyl, A300-175A). Antibodies targeting the super elongation fac-
tors AFF4 and ELL2 were provided by Ali Shilatifard. Immunoprecipitation was performed for approximately 12 hours at 4C using
protein A/G plus agarose beads (Santa Cruz, sc2003). Bead-containing samples were then washed as previously described (Gomes
et al., 2006). Immunocomplexes were eluted by incubation at 65C for 10 min in the presence of 1% SDS, and crosslinking was
reversed by 6 h incubation at 65C in the presence of 200 mM NaCl. DNA was purified by the QIAquick spin kit (QIAGEN) and further
assessed by qPCR using the LightCycler 480 system from Roche. Data were normalized to input and expressed relative to the
nonspecific IgG or IgM ChIP controls. Primer sequences can be obtained on request.
ChIP-seq
Chromatin samples were prepared as previously described (Mishra et al., 2018). In brief, ESCs grown on 15 cm dish were crosslinked
with 1% formaldehyde for 10 min at 37C. Crosslinking was quenched with 0.125M glycine for 5 min at 37C. Collected cell pellets
from each 15 cm dish were resuspended in 2.5 mL lysis buffer supplemented with protease inhibitors (5 mMPIPES pH8, 85mMKCL,
0.5%NP40) and incubated 5min at 4C.Chromatin was obtained by centrifugation at 800 rpm for 5min at 4C,where nuclear fraction
from approximately 10 to 12million cells were resuspended in 300 mL of nuclear lysis buffer (50mMTris-HCL pH8, 10mMEDTA pH8,
0.2% SDS). Chromatin was then sonicated at 70% amplitude 15 s ON and 45 s OFF for 45 min. About 5 mL of sonicated chromatin
was reverse-crosslinked with 1 mL of proteinase K in elution buffer (50 mMNaHCO3, 140 mMNaCl, 1% SDS) at 65
C overnight. After
RNase treatment, DNAwas isolated by phenol chloroform extraction and analyzed on 1%agarose gel electrophoresis. Only samples
with smear below 300 bp were used for ChIP-seq analysis. Approximately 10 to 30 mg of pre-cleared chromatin was used per each
immunoprecipitation with magnetic beads conjugated with2 mg of antibody in IP buffer (16.7 mMTris HCL pH8, 1.2mMEDTA pH8,
167mMNaCl, 0.01%SDS, 1.1%Triton x-100) at 4Covernight. The immunoprecipitated DNAwaswashed twice with IP buffer, once
with TSE buffer (20 mM Tris HCL pH8, 2 mM EDTA pH8, 500 mM NaCl, 1% Triton x-100, 0.1% SDS), once with LiCl buffer (100 mM
Tris HCL pH8, 500mMLiCl, 1%deoxycholic acid, 1%NP40) and twicewith TE-buffer (10mMTris-HCL pH8, 1mMEDTA pH8) before
elution by incubation in elution buffer (50mMNaHCO3, 140mMNaCl, 1%SDS) supplementedwith 10 mg of proteinase K at 55
C for 1
hour. The samples were removed from the magnetic beads and reverse-crosslinked at 65C for 4 hr. Immunoprecipitated DNA was
purified using PCR purification columns from QIAGEN. Construction of the DNA libraries for DIP sequencing were performed with
Illumina reagents and sequencer equipment.
Chromatin immunoprecipitations were performed with the following antibodies: from Cell Signaling Technology we used anti-Pol
II(Rpb1 CTD, 4H8) (Cat# 2629), anti-SIRT6(D8D12) (Cat# 12486S), anti-H3K79me2(D15E8) (Cat# 5472), anti-H3K36me3(D5A7) (Cat#
4909); Anti-H3K9ac (Millipore 07-352), anti-H3K56ac (abcam ab76307), and anti-LEO1 (Bethyl A300-175A).
ChIP-seq Heatmap Creation
Reads fromRNAPol II, SIRT6, andHDACI ChIP-seq for bothWT andSIRT6KOESCswere aligned tomouse genomemm9using bwa
and duplicate reads were marked with Picard tools (http://picard.sourceforge.net). The heatmaps of Figure 2A were produced by
calculating the mean coverage values of 100bp windows in the ± 3kb region centered on the TSS for all genes using the ChIP-
seq data for SIRT6 and Pol II in ESC cells. The heatmaps represent the mean enrichment by bin after correcting for the direction
of the DNA strand. For the heatmap after filtering out genes with insufficient signal, coverage values for the genes z-score normalized
and then ordered by hierarchical clustering using Euclidean distance andWardmethod of the R heatmap.2 function. The list includes
genes that passed the cutoffs for at least one of Pol II, and SIRT6, and only the top 400 genes for each sample are displayed. To
assess the enrichment of ChIP-seq signal across gene body regions (Figure 2E), we calculated the ratio of ChIP to input sequencing
tag number in the region of the gene body excluding the immediate 3 Kb proximity of TSS. These enrichment values for the gene set of
interest were compared between Sirt6 KO and wild-type using t test.
CUT&RUN
These experiments were performed as described by Skene and Henikoff (Skene et al., 2018) with modifications. Briefly, mouse ESCs
(1 million) were fixed with 1% paraformaldehyde (PFA) and quenched with 125 mM glycine. After centrifugation at 400xg, cell
pellets were washed three times with PBS and twice with HEPES buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.5% BSA, 0.1%
Tween 20). Activated concanavalin A-coated magnetic beads (Bangs Laboratories) were added to capture the cells, which were
incubated at 4C overnight with antibodies targeting H3K27me3 (cell Signaling Cat# 9733), H3K9ac (Millipore Cat# 07-352),
NELF-E (AbcamCat# ab170104), IgG control (Antibody-online Cat# ABIN101961). IgG andH3K27me3 antibodies served as negative
and positive controls, respectively. Immunoprecipitated samples were supplemented with protein A-MNase (700 ng/ml) and
incubated for 1 hour at 4C and placed on ice. Protein A-MNase was activated by incubation with 2 mM CaCl2 on ice for 30 min.
This reaction was terminated with stop buffer (340 mM NaCl, 20 mM EDTA, 4 mM EGTA, 0.1% Tween 20, 50 ug/ml RNaseA,
50 ug/ml glycogene, 0.05 pg/ml heterologous yeast spike-in DNA). CUT&RUN fragments were released by incubation at 37CMolecular Cell 75, 1–17.e1–e7, August 22, 2019 e4
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Library preparations were done based on Skene and Henikoff method (Skene et al., 2018) followed by Tapestation analysis to
assess the quality of DNA libraries.
PRO-seq library preparation and data analysis
Wild-type mouse ESCs of (WT), or SIRT6-KO (KO) genotypes, or WT cells that were glucose-starved (No Glucose) for 48hr. were
permeabilized at 4C or on ice unless otherwise specified. Briefly, cells were washed once in ice-cold 1x PBS and resuspended
in Buffer W (10mMTris-HCl pH 8.0, 10%glycerol, 250mM sucrose, 10mMKCl, 5 mMMgCl2, 0.5mMDTT, protease inhibitors cock-
tail (Roche), and 4 u/mL RNase inhibitor (SUPERaseIN, Ambion)) at the cell density of 23 107 cells/mL. 9x volume of Buffer P (10 mM
Tris-HCl pH 8.0, 10% glycerol, 250 mM sucrose, 10 mM KCl, 5 mM MgCl2, 0.5 mM DTT, 0.1% Igepal, protease inhibitors cocktail
(Roche), 4 u/mL RNase inhibitor (SUPERaseIN, Ambion)) was then immediately added. Cells were gently resuspended and incubated
for up to 2 min on ice. Cells were then recovered by centrifugation (800 x g for 4 min) and washed in Buffer F (50 mM Tris-HCl pH 8.0,
40% glycerol, 5 mM MgCl2, 0.5 mM DTT, 4 u/mL RNase inhibitor [SUPERaseIN, Ambion]). Washed permeabilized cells were finally
resuspended in Buffer F at a density of 13 106 cells/30 mL and immediately frozen in liquid nitrogen. Permeabilized cells were stored
in 80C until usage.
PRO-seq run-on reactions were carried out as follows: 13 106 permeabilized cells spiked with 53 104 permeabilized Drosophila
S2 cells were added to the same volume of 2x Nuclear Run-On reaction mixture (10 mM Tris-HCl pH 8.0, 300 mM KCl, 1% Sarkosyl,
5 mM MgCl2, 1 mM DTT, 200 mM biotin-11-A/C/G/UTP (Perkin-Elmer), 0.8 u/mL SUPERaseIN inhibitor (Ambion)) and incubated for
5min at 30C.Nascent RNAwas extracted using a Total RNAPurification Kit following themanufacturer’s instructions (Norgen Biotek
Corp.). Extracted nascent RNA was fragmented by base hydrolysis in 0.25 N NaOH on ice for 10 min and neutralized by adding
1x volume of 1 M Tris-HCl pH 6.8. Fragmented nascent RNA was bound to 30 mL of Streptavidin M-280 magnetic beads (Thermo
Fisher Scientific) in Binding Buffer (300 mM NaCl, 10 mM Tris-HCl pH 7.4, 0.1% Triton X-100). The beads were washed twice in
High salt buffer (2 M NaCl, 50 mM Tris- HCl pH 7.4, 0.5% Triton X-100), twice in Binding buffer, and twice in Low salt buffer
(5 mM Tris-HCl pH 7.4, 0.1% Triton X-100). Bound RNA was extracted from the beads using Trizol (Invitrogen) followed by ethanol
precipitation.
For the first ligation reaction, fragmented nascent RNAwas dissolved in H2O and incubated with 10 pmol of reverse 3
0 RNA adaptor
(50p-rNrNrNrNrNrNrGrArUrCrGrUrCrGrGrArCrUrGrUrArGrArArCrUrCrUrGrArArC-/30InvdT/) and T4 RNA ligase I (NEB) under manu-
facturer’s conditions for 2 h at 20C. Ligated RNA was enriched with biotin-labeled products by another round of Streptavidin bead
binding and washing (two washes each of High, Binding and Low salt buffers and one wash of 1x Thermo Pol Buffer (NEB)). To decap
50 ends, the RNA products were treated with RNA 50 Pyrophosphohydrolase (RppH, NEB) at 37C for 30 min followed by one wash of
High, Low and T4 PNK Buffer. To repair 50 ends, the RNA products were treated with Polynucleotide Kinase (PNK, NEB) at 37C
for 30 min.
50 repaired RNAwas ligated to reverse 50 RNA adaptor (50-rCrCrUrUrGrGrCrArCrCrCrGrArGrArArUrUrCrCrA-30) with T4 RNA ligase
I (NEB) under manufacturer’s conditions for 2 h at 20C. Adaptor ligated nascent RNA was enriched with biotin-labeled products by
another round of Streptavidin bead binding and washing (two washes each of High, Binding and Low salt buffers and one wash of
1x SuperScript IV Buffer (Thermo Fisher Scientific)), and reverse transcribed using 25 pmol RT primer (50- AATGATACGGCGACCA
CCGAGATCTACACGTTCAGAGTTCTACAGTCCGA-30) for TRU-seq barcodes (RP1 primer, Illumina). A portion of the RT product
was removed and used for trial amplifications to determine the optimal number of PCR cycles. For the final amplification, 12.5
pmol of RPI-index primers (for TRU-seq barcodes, Illumina) was added to the RT product with Phusion polymerase (NEB) under stan-
dard PCR conditions. Excess RT primer served as one primer of the pair used for the PCR. The product was amplified 1214 cycles
and beads size selected (ProNex Purification System, Promega) before being sequenced in NextSeq 500 machines in a mid-output
150-bp cycle run.
PRO-seq libraries from 3 independent biological replicates (WT and KO) or 2 biological replicates (NG) were generated. Paired-end
reads were trimmed to 40 nt, for adaptor sequence and low quality 30 ends using cutadapt 1.14, discarding those containing reads
shorter than 20 nt (-m 20 -q 10), and removing a single nucleotide from the 30 end of all trimmed reads to allow successful alignment
with Bowtie 1.2.2 (Langmead, Trapnell et al., Genome Biol. 10, R25, 2009). Remaining pairs were paired-end aligned to the dm3
genome index to determine spike-normalization ratios based on uniquely mapped reads. Mappable pairs were excluded from further
analysis, and unmapped pairs were aligned to the mm9 genome assembly. Identical parameters were utilized in each alignment
described above: up to 2 mismatches, maximum fragment length of 1000 nt, and uniquely mappable, and unmappable pairs routed
to separate output files (-m1, -v2, -X1000,–un). Pairs mapping uniquely to mm9, representing biotin-labeled RNA 30 ends, were
separated, and strand-specific counts of the 30 mapping positions determined at single nucleotide resolution, genome-wide, and
expressed in bedGraph format with ‘‘plus’’ and ‘‘minus’’ strand labels swapped for each 30 bedGraph, to correct for the ‘‘forward/
reverse’’ nature of Illumina paired-end sequencing (Mahat et. al., 2016). Counts of pairs mapping uniquely to spike-in RNAs
(Drosophila genome) were determined for each sample. Uniquely mappable reads were determined, and a normalization factor
calculated. In this case, the spike in reads exhibited no systematic differences across samples, thus normalization based on
sequencing depth was used for each bedGraph. PRO-seq size factors used were: for WT 1.70255924, 3.35361899, 1.04422773;
KO: 2.19052323, 3.46076838, 1.00000000; and NG: 3.22211594, 3.16824971. To account for the different number of replicates
used in NoGlucose condition (N = 2) theWT and KO datasets (each N = 3) were downsampled by 2/3 to facilitate direct comparisons.e5 Molecular Cell 75, 1–17.e1–e7, August 22, 2019
Please cite this article in press as: Etchegaray et al., The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal
Pausing, Molecular Cell (2019), https://doi.org/10.1016/j.molcel.2019.06.034Combined bedGraphs were generated by summing counts per nucleotide of all replicates for each condition; and UCSC Genome
Browser tracks displayingmean read coveragewere generated from the combined replicates per condition, normalized as described
above.Sample Total reads Uniquely mapped reads
(Percentage of total)
Agreement between replicates
(Spearman’s rho)
WT (Wild-type) 331,008,473 36.68% > 0.97
KO (SIRT6-KO) 340,699,369 33.10% > 0.97
NG (No-Glucose) 250,932,240 42.53% 0.99Pausing Indices and composite analyses of PRO-seq signals
TSSs were designated as bound by Pol II if there were a total of 16 reads in WT bedGraphs (without normalization) in the region ±
150 bp from the annotated TSS. 12,941 of 17,032 TSSs (76.0%) were classified as Pol II-bound using this cutoff, of which 3,659
are upregulated genes in RNA-seq upon SIRT6-KO. Composite metagene distributions were generated by summing sequencing
reads at each indicated position with respect to the TSS and dividing by the number of TSSs included within each group. These
were plotted across a range of distances. Zoomed-in PRO-seq profiles (e.g., Figures 2G–2I) were smoothed by calculating a moving
average across adjacent 5 bins.
QUANTIFICATION AND STATISTICAL ANALYSIS
Gene expression, transcription factor binding and in vitro transcription analysis
Standard 2-sample t test assuming equal variance was used to calculate gene expression levels, transcription factor binding
and elongation products, from RT-qPCR, ChIP-qPCR and in vitro transcription elongation experiments, respectively. The
‘‘n’’ values represent aminimum of 3 biological replicas, and the error bars correspond to s.e.m. calculated using analysis of variance
(ANOVA).
ChIP-seq analysis
Sequencing reads were aligned against the mm9 reference genome using BWA (Li and Durbin, 2010). Alignments were filtered for
uniquely mapped reads and duplicates were removed. Input-normalized coverage tracks were generated using SPP; enrichment
peaks were called using SPP as broad regions of enrichment with FDR cutoff of 0.01 (Kharchenko et al., 2008). Regions of differential
tag enrichment were determined based on tag counts in all identified peak regions using Diffbind (Ross-Innes et al., 2012) with FDR
cutoff 0.1. These regions of differential enrichment between SIRT6 KO and WT ESCs were then analyzed for the proximity (within
20 Kb) to the differentially expressed genes detected in RNA-seq analysis. Reads from H3K9Ac, H3K56Ac, H3K36me3,
H3K79me2, Pol II, and LEO1 ChIP-seq for WT and SIRT6 KO ESCs, and H3 control for mouse ESCs were aligned to mouse genome
mm9 using bwa and duplicate reads were marked with Picard tools (http://picard.sourceforge.net). Peaks were called using MACS2
version 2.1 with the False Discovery Rates (FDR) q = 0.01 with the ‘—broad’ flag. A subset of called peaks were checked visually with
the IGV browser. The Bioconductor package DiffBind was used to find differentially bound ChIP-seq peaks for all the histone marks
and factors using H3 ChIP-seq as an input control. Differential binding statistics in DiffBind were calculated with DESeq2 with an FDR
threshold of 0.1. Differentially bound peaks with FDR < 0.1 were assigned to genes if they fell within ± 20kb of the gene body using
Bioconductor ‘TxDb.Mmusculus.UCSC.mm9.knownGene’ annotation. Gene Ontology (GO) categories were assigned to genes
using the functional annotation table method in DAVID functional annotation tool version 6.8 (https://david.ncifcrf.gov). p values
were obtained using standard 2-sample t test assuming equal variance. Pearson correlations between replicates were calculated
by covering over 10Kb windows across the genome for all the different ChIP-seqs (see Figure S6).
Pausing Index calculated from Pol II ChIP-seq analysis
Reads from RNA Pol II ChIP-seq for WT and SIRT6 KO ESCs were aligned to mouse genome mm9 using bwa and duplicate reads
were marked with Picard tools (http://picard.sourceforge.net). Pausing Indexes (PI) were calculated as the Pol II ChIP-seq density
ratios between the promoter and the gene body regions in genes with significant Pol II signal in the promoter region (FDR < 1e-3
from SISSRs) generally following the methods used in Nechaev et al. (2010) and Henriques and Adelman (2013). The promoter
was defined as the TSS ± 150bp while the gene body was defined as +250bp to +2250bp (or the gene end if the gene is less
than 2250bp). Figure 2E shows the fraction of RNA Pol II bound genes with a PI greater than or equal to the value of the PI value
on the x axis for WT and SIRT6 KO. Figure 2E shows average pausing for two replicates each of WT and SIRT6 KO ESC ChIP-
seq data for RNA Pol II for genes that were upregulated in SIRT6 KO RNA-Seq samples with DESeq2 adjusted p value < 0.1
(4938 genes). There were 2459 unique genes that had greater than 2-fold decrease in pausing index for SIRT6 KO of the 4938 genes
that were upregulated in SIRT6 KO ESCs (Tables S1 and S3).Molecular Cell 75, 1–17.e1–e7, August 22, 2019 e6
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Pausing, Molecular Cell (2019), https://doi.org/10.1016/j.molcel.2019.06.034RNA-Seq data analysis
Read counts were calculated per gene, in a strand-specific manner, based upon alignments to the UCSCmousemm9 transcriptome
using tophat2 version 2.0.10 and htseq version 0.6.1, and finally differentially expressed genes were found using the Bioconductor
package DESeq2. Differentially expressed genes were defined using an adjusted p value threshold of < 0.1. Of 23,366 genes, 4938
were identified as differentially expressed upon SIRT6-KO in mESC cells. p values were obtained using standard 2-sample t test
assuming equal variance.
CUT&RUN data analysis
CUT&RUN sequenced reads were aligned to mouse mm9 and yeast S288C reference genome using BWA. Mouse alignments were
filtered for uniquely mapped reads and duplicates were removed, then mouse profiles were normalized to the number of aligned
heterologous yeast spike-in genomic DNA reads. Metagene profiles were generated using deeptools (Ramirez et al., 2016).
Pausing Index calculated from PRO-seq analysis
Genomic statistical tests: Statistical significance for comparisons of promoter (±150 nt from TSS) and gene body (+250 to +1250 nt
from TSS) betweenWT and KO or NG conditions was assessed byMann-Whitney test. Statistical details and error bars are defined in
each figure legend. Spearman correlations were calculated by using a ± 250bp window around promoters (N = 17032) of annotated
genes for each of the replicates in WT, WT No Glucose or SIRT6-KO conditions (see Figure S7).
DATA AND CODE AVAILABILITY
GEO Accession numbers
All the raw datasets for the different sequencing experiments have been deposited in NCBI. The accession number for these different
sequencing experiments are: GEO: GSE130689, GEO: GSE130690, GEO: GSE130691, and GEO: GSE130692.e7 Molecular Cell 75, 1–17.e1–e7, August 22, 2019
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SUPPLEMENTAL FIGURE LEGENDS 
Figure S1, related to Figure 1: 
Figure S1A. ChIP-qPCR for SIRT6 on Ldhb and Glut1 genes. Data (n=3) was normalized to input and 
IgG-ChIP controls. Data are presented as ratios where values from SIRT6 KO ESCs (red) are equal to 
1. (*: p < 0.05, **: p < 0.005, n = 3. Error bar represents s.e.m). 
Figure S1B. Venn diagram showing the overlapping between up-regulated genes in SIRT6 KO ESCs 
and H3K9ac/H3K56ac enriched genes in SIRT6 KO ESCs.  
Figure S1C. Increased H3K9ac and H3K56ac levels in SIRT6 KO ESCs at specific genes. IGV broswer 
images from H3K9ac and H3K56ac ChIP-seq showing enrichment in SIRT6 KO (red) compared to WT 
ESCs (black) on genes involved in metabolism, neural development and pluripotency. 
 
Figure S2, related to Figure 2: 
S2A. Decreased Pol II pausing in SIRT6 KO ESCs at specific genes. IGV broswer images from 
elongating Pol II ChIP-seq showing increased levels in SIRT6 KO (red) versus WT ESCs (black) on 
genes involved in metabolism and neural development. S2B. Pie charts showing functional gene 
categories for the up-regulated genes in SIRT6 KO ESCs. Biological processes were determined by 
gene onthology analysis using Panther classification system (Thomas et al., 2003). S2C. Western blot 
showing direct interaction between endogenous SIRT6 and Pol II by co-immunoprecipitation assays 
using whole cell extracts from WT ESCs (+/- ethidium bromide). S2D. Western blot showing co-
immunoprecipitation between SIRT6 and the Pol II subunit, RPB2, using nuclear extracts from WT and 
SIRT6 KO ESCs. S2E. Western blots showing co-immunoprecipitation between RPB2 and SIRT6 using 
nuclear extracts derived from WT, WT deprived of glucose and SIRT6 KO ESCs. S2F. Mass 
spectrometry analysis from HeLa cells overexpressing SIRT6 showing the enrichment for RPB2, TOP2A 
and MED23. S2G. Venn diagram from Pol II ChIP-seq analysis showing that nearly 50% of the up-
regulated genes in SIRT6 KO ESCs have lower Pausing Index compared to WT cells. S2H. Venn 
diagram from PRO-seq analysis showing about 75% of the up-regulated genes in SIRT6 KO ESCs have 
lower Pausing Index compared to WT cells. S2I. Biolin plots from PRO-seq analysis showing the 
significant decrease of Pol II levels near promoter-proximal regions in SIRT6 KO (red) and glucose 
starved WT (green) ESCs compared to WT (black) control cells. This plots also show a significant 
increase in Pol II levels at gene bodies of up-regulated genes in SIRT6 KO (red) or glucose deprived 
WT (green) ESCs.  S2J. Metagene profile showing Pol II levels in unchanged genes between WT (black) 
and SIRT6 KO (gray) ESCs. S2K. Violin plots from PRO-seq analysis showing the significant decrease 
of Pol II levels near promoter-proximal regions in unchanged genes between SIRT6 KO (gray) and WT 
(black) ESCs. However, there is no significant changes in Pol II levels at gene bodies in these genes.  
 
Figure S3, related to Figure 3: 
S3A. Western blots showing the ectopic expression of SIRT6 rescues the decrease in chromatin-bound 
NELF-E in SIRT6 KO ESCs. S3B. Western blots showing levels of NELF-E and histone H3 in WT ESCs 
at various time-points after glucose starvation, and SIRT6 KO ESCs.  S3C. Venn diagram showing the 
overlap between genes that demonstrate a reduction in Pausing Index and the levels of NELF-E binding 
in ESCs lacking SIRT6. S3D. Scatter plot showing high level of association between CUT&RUN and 
ChIP-seq data for H3K9ac. S3E. Decreased localization of NELF-E near pausing sites on SIRT6 target 
genes in both SIRT6 KO and WT ESCs grown under conditions of glucose starvation. NELF-E ChIP-
qPCR on Ldhb or Glut1 genes in WT ESCs grown in normal conditions (high glucose; black) or under 
glucose starvation (low glucose; grey), and in SIRT6 KO ESCs grown in normal levels of glucose. Data 
was normalized to input and IgG ChIP control. Error bars represents s.e.m (*: p < 0.05, **: p< 0.01, ***: 
p< 0.001, n = 3). S3F. Western blots showing co-immunoprecipitation of CDK9 with Pol II and Pol II 
Ser2P. 
 
Figure S4, related to Figures 4-6: 
S4A. Western blot analysis showing decreased levels of Pol II Ser2P and CDK9 in chromatin fractions 
from SIRT6 KO ESCs after acute siRNA-mediated depletion of MYC. S4B. Western blots showing 
increased levels of BRD4 in chromatin, but not cytosolic fractions from SIRT6 KO versus WT ESCs. 
S4C. Western blots showing the rescue of PDK1 and LDH up-regulation upon siRNA-dependent 
depletion of BRD4 in SIRT6 KO ESCs. S4D. Increased recruitment of the PAF1 complex subunit LEO1 
in SIRT6 KO ESCs at specific genes. IGV browser images from LEO1 ChIP-seq in SIRT6 KO (red) 
versus WT ESCs (grey) on genes implicated in metabolism, ribosomal biogenesis, neural development 
and pluripotency. IGV browser images of genes with no differences in LEO1 levels between WT and 
SIRT6 KO ESCs are included as controls.  
 
Figure S5, related to Figure 7: 
S5A. List of genes enriched for H3K9ac, H3K56ac, H3K36me3 and H3K79me2. These genes are 
exclusively involved in metabolism and neural development. S5B. Lower exposure film of the in vitro 
transcription elongation assay in Figure 7G.  
 
Figure S6, related to Methods (Chip-Seq analysis): 
Pearson Correlation plots for ChIP-seq in WT and SIRT6 KO ESCs (n=2): (A) H3K9ac, (B) H3K56ac, 
(C) Pol II, (D) LEO1, (E) H3K36me3, (F) H3K79me2. Pearson R between replicates were calculated by 
covering over 10Kb windows across the genome. 
 
Figure S7, related to Methods (Genomic Statistical tests): 
A-C. Correlation plots from PRO-seq analysis between WT (S7A), SIRT6 KO (S7B) and glucose starved 
WT (S7C) ESCs. Spearman correlations (r) were calculated by using a +/- 250bp window around 
promoters (N=17032) of annotated genes for each of the replicates in WT, WT No Glucose or SIRT6-
KO conditions. 
